Catalyst Wire Dossier Catalyst Wire Dossier

Alloreactive NK cell therapy

Natural killer cells · IRCCS Azienda Ospedaliero-Universitaria di Bologna
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alloreactive NK cell therapy, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients [NA]

See pricing